Skip to main content
Preview

Research from Friday’s close · next update overnight after Monday’s close

Radar
DOW

DOW Research brief

Dow Inc.

Adjusted close as of 2026-10-30
$34.70(+3.21%)

Sagehood’s view on DOW

Dow Inc. · Research 2026-10-30 · Accepted

Research score

48Neutral50 is balancedScore change +4 since 2026-10-29, from 44 to 48; view changed from Bearish to Neutral. Compare the two recordsConfidence 50 · It is not a calibrated probability of investment success.Confidence across the 100 names in this research run: 45 to 70, median 55.
How to read this score

Dated research brief

WhyDOW looks neutral because revenue fell 7.7% and trailing-twelve-month free cash flow was −$232 million, leaving cash generation short. The unresolved risk is that the 24.06% twenty-day gain already prices in the cost-cut recovery.
What argues against this viewThe strongest case against the neutral view is the confirmed Q3 earnings reaction, up 5.89% on day one and 11.88% over three sessions. If cost cuts keep lifting profit, the two-name comps median of $83.08 implies 139.4% upside from the $34.70 close.
Break conditionFrom the financial specialist: A later reading showing trailing-twelve-month revenue growth below the 8.7% revenue-growth median would confirm the contraction already visible.Tests that specialist’s reading, not this page’s whole Neutral view.

Sagehood does not check this condition automatically. See research limitations below.

A newer 10-Q (filed 2026-10-23) is on record; some figures here may predate it.

Valuation range

No model fair value for this run

Cash-flow model unavailable: the recorded total debt, net debt are missing or invalid. Other valuation methods retain their own checks.

Peer-implied median $83.08 from 2 peer-median multiples.

Against peers

Materials
MultipleDOWGroup medianPercentile
P/S0.64×2.02×50th
P/B1.55×2.50×50th
FCF yield−0.93%−16.22%100th
Score details & research limitations9 unavailable fields
Conditions Sagehood can check on its ownNot available in this run. A written break condition is not an automated check; this run does not provide a source-linked rule Sagehood can verify on its own.

Where the break condition comes from: Sagehood research took this condition from the financial specialist. It tests that specialist’s own reading, so it does not say everything that would change this page’s Neutral view.

How to read this research

The score expresses the published research view. 50 is balanced.

Bullish, Neutral or Bearish beside the score is the direction of that view, set by the research from the score: 65 and above is Bullish, 45 to 64 Neutral, 44 and below Bearish.

Confidence is how well the evidence supports this view, not which way it points: Sagehood research is asked to keep it no higher than its most confident specialist, and lower when the specialists disagree or much of the evidence is weak. It is not a calibrated probability of investment success.

Source verification checks the identity and origin of evidence. It does not prove that a claim is correct or that an investment will succeed.

Valuation estimates depend on their inputs and assumptions. They are not guaranteed future prices.

Retrospective research looks back at an earlier period. It is not a verified record of a decision made then using only information available then.

Unavailable is not zero. Read the adjacent reason: information may be missing, unverified or deliberately withheld.

How Sagehood works

The session this view is fixed to

Close$34.70 on 2026-10-30, as the research recorded it
Change on the day+3.21%
First eligible market session2026-11-02

Recorded score context

Specialist source coverage8 of 10 specialists have a verified source on this run. 2 do not.
Score reconciliationThe 8 specialist contributions shown add up to the weighted starting point this score was built from.
Change since the last accepted run44 on 2026-10-29 → 48 on 2026-10-30 (+4 points). This is simple arithmetic between the two published scores, not an explanation of the change.
The run this is compared withResearch of 2026-10-29

Not in this run: Run-specific score definition, Confidence band, Horizon, Why the score changed, Today's unexplained move and Blockers.

What this was built from

Filing cited in the evidenceNot recorded on this card. The newest filing on record is under Key financials, and recent filings are listed under SEC filings.
Peer set2 names in Materials: FCX, MOS. How they were chosen is under “Valuation & peers”. The valuation range shows the peer-implied median from 2 peer-median multiples.

Not in this run: Company profile date and Standing disclosure.

Not available in this run

9 fields are unavailable. Each is identified with its reason above; missing information is not zero or a negative research signal.

Price context

· adjusted close $34.70

+19.8% from 2026-06-25

Recent price-basis check: 2026-10-02 to 2026-10-30 (20 sessions). Economic comparability outside this window remains unchecked.

DOW adjusted close
Adjusted price · USD · viewing 2026-06-25 to 2026-10-30

Selected 2026-10-30. DOW adjusted close. Continuous series. $34.70 US dollars.

90 daily adjusted-price observations through 2026-10-30, ending at the 2026-10-30 research date. The final point is a dated final close. Shown for context, not point-in-time research evidence: the research used the prices recorded with it.

Use the arrow keys on the chart to step through observations.

Published score history

2026-07-23 to 2026-10-30 · 37 publications

Each point is a verified published score. The line breaks where the research method changed (4 methods, numbered in the order they were first used), so scores are not joined across methods. Hollow points were published after their decision window (retrospective).

Every published score and confidence
Research dateScoreViewConfidenceMethod
2026-10-3048Neutral50Method 4
2026-10-2944Bearish55Method 4
2026-10-2845Neutral49Method 4
2026-10-2742Bearish60Method 4
2026-10-2650Neutral50Method 4
2026-10-2350Neutral50Method 4
2026-10-2250Neutral60Method 4
2026-10-2145Neutral49Method 4
2026-10-1640Bearish50Method 4
2026-10-0938Bearish60Method 4
2026-10-0736Bearish55Method 4
2026-10-0236Bearish58Method 4
2026-10-0139Bearish55Method 4
2026-09-3039Bearish55Method 4
2026-09-2939Bearish55Method 4
2026-09-2847Neutral49Method 4
2026-09-2540Bearish55Method 4
2026-09-24 · retrospective38Bearish55Method 4
2026-09-2340Bearish55Method 4
2026-09-1841Bearish55Method 4
2026-09-16 · retrospective36Bearish60Method 4
2026-09-09 · retrospective48Neutral45Method 4
2026-09-0436Bearish50Method 4
2026-09-01 · retrospective40Bearish50Method 4
2026-08-31 · retrospective45Neutral40Method 3
2026-08-2842Bearish68Method 3
2026-08-26 · retrospective45Neutral40Method 3
2026-08-24 · retrospective48Neutral59Method 3
2026-08-20 · retrospective48Neutral59Method 3
2026-08-19 · retrospective45Neutral40Method 3
2026-08-1445Neutral40Method 2
2026-08-1343Bearish68Method 1
2026-08-0743Bearish68Method 1
2026-08-0646Neutral40Method 1
2026-08-0448Neutral40Method 1
2026-07-3145Neutral51Method 1
2026-07-2347Neutral60Method 1

Specialists

8 of 10 published specialist analyses are available.

Each specialist’s view is shown as the published research recorded it; supporting detail appears only when it was recorded with that same view.

2 unavailable

DOW research

Financial specialist

Showing Financial specialist result.

Financial specialist

Evaluated for this session

Bearish

Dow shows a contracting top line, with trailing-twelve-month revenue of $39,331 million down 7.7% and trailing-twelve-month free cash flow of −$232 million, while total debt and net debt to EBITDA are not available, leaving the balance-sheet risk unquantified.

Full analyst note

What the specialist sees

Evidence: trailing-twelve-month revenue was $39,331 million with revenue growth of −7.7% and quarterly revenue growth of −7.4%, −8.3%, −9.1% and −6.1%, while trailing-twelve-month free cash flow was −$232 million against trailing-twelve-month operating cash flow of $2,065 million.

Why it matters now

Persistent revenue declines and negative free cash flow of −$232 million point to a business whose cash generation no longer covers its capital spending, with debt principal unobserved.

What could change the view

Countercase: Debt principal and net debt to EBITDA are not available, so the balance-sheet read rests on cash and equity alone and could be wrong. Falsifier: A later reading showing trailing-twelve-month revenue growth below the 8.7% revenue-growth median would confirm the contraction already visible.

Specialist score details
Specialist score
30
Evidence confidence
70
Base weight for this role
0.13
Base weight × confidence
9.10
Weight in the score (the chip's weight)
0.19
Weighted contribution
5.81
Business driver
Trailing-twelve-month revenue was $39,331 million with revenue growth of −7.7% and quarterly revenue growth of −7.4%, −8.3%, −9.1% and −6.1%, while trailing-twelve-month free cash flow was −$232 million against trailing-twelve-month operating cash flow of $2,065 million.
Mechanism
Persistent revenue declines and negative free cash flow of −$232 million point to a business whose cash generation no longer covers its capital spending, with debt principal unobserved.
Countercase
Debt principal and net debt to EBITDA are not available, so the balance-sheet read rests on cash and equity alone and could be wrong.
Contributions & coverage details

Specialist contributions

Each specialist’s recorded numbers, in the usual specialist order, as recorded: nothing is re-ranked or recalculated. Weights and contributions show two decimals; hover for the exact value.

Financial specialist

Bearish

Score
30
Evidence confidence
70
Weight in the score
0.19
Weighted contribution
5.81

Risk specialist

Neutral

Score
45
Evidence confidence
55
Weight in the score
0.09
Weighted contribution
4.21

Sector specialist

Neutral

Score
50
Evidence confidence
52
Weight in the score
0.11
Weighted contribution
5.53

SEC filings specialist

Neutral

Score
50
Evidence confidence
50
Weight in the score
0.03
Weighted contribution
1.60

News specialist

Neutral

Score
62
Evidence confidence
60
Weight in the score
0.14
Weighted contribution
8.71

Price-trend specialist

Neutral

Score
55
Evidence confidence
55
Weight in the score
0.23
Weighted contribution
12.87

Valuation specialist

Neutral

Score
50
Evidence confidence
30
Weight in the score
0.10
Weighted contribution
5.11

Economy specialist

Neutral

Score
54
Evidence confidence
55
Weight in the score
0.09
Weighted contribution
5.06

Published specialist analyses unavailable: Geopolitics specialist, Social-media specialist. No specialist result is inferred.

  • Geopolitics specialist: This specialist had no checked public source on this run, so no source-backed analysis is shown.
  • Social-media specialist: This specialist had no checked public source on this run, so no source-backed analysis is shown.

How this insight was formed

Each specialist view shown here is checked against the published research files. Sagehood research combined those views into the one Research Score above.

Evidence & method

Inspect the reasoning, source records and valuation behind this dated view.

Sagehood research reasoningSpecialist reasoning, selected statements and filing context
Accepted publication2026-10-30 researchNext eligible session 2026-11-02point-in-time

DOW: Sagehood research reasoning

Accepted research score

48

Neutral50 is balanced
Lead specialist in the research decision:

Financial specialist

Bearish

Specialist score 30Evidence confidence 70
What the specialist sees

Trailing-twelve-month revenue was $39,331 million with revenue growth of −7.7% and quarterly revenue growth of −7.4%, −8.3%, −9.1% and −6.1%, while trailing-twelve-month free cash flow was −$232 million against trailing-twelve-month operating cash flow of $2,065 million.

Why it matters

Persistent revenue declines and negative free cash flow of −$232 million point to a business whose cash generation no longer covers its capital spending, with debt principal unobserved.

What argues against it

Debt principal and net debt to EBITDA are not available, so the balance-sheet read rests on cash and equity alone and could be wrong.

This specialist’s break condition: A later reading showing trailing-twelve-month revenue growth below the 8.7% revenue-growth median would confirm the contraction already visible.

How the score was formed

The specialists’ weighted starting point was 48.89. Sagehood research’s adjustment was −0.89. 44 on 2026-10-29 → 48 on 2026-10-30 (+4 points). This is simple arithmetic between the two published scores, not an explanation of the change.

Evidence Sagehood research weighed

These selected claims are evidence Sagehood research weighed, not a reconstruction of the numeric adjustment.

Claims as this research published them. Sagehood confirms each claim and its support were published together with this research. That is not an independent check, and it does not prove the claim is accurate or predict future performance.

  1. Financial specialist

    Same statement as under “What the specialist sees” above.

  2. News specialist

    DOW closed 2026-10-30 at 34.7, up 3.21% on the day and 24.06% over 20 days, with material-news net tone +0.13 and good-news days followed by outperformance 7 against bad-news days followed by underperformance 0. The 2026-10-22 items 'Dow's Profit Rises Sharply on Cost Cuts...' and 'Dow Inc.: Q3 Earnings Snapshot' each showed one-day return relative to SPY 5.89 percentage points and three-session return after the news 11.88%, and an 8-K dated 2026-10-22 carried items 2.02,9.01.

  3. Price-trend specialist

    DOW closed at 34.7, up 24.06% over 20 days and 15.85% over 60 days, with a 90-day channel slope of 17.5% per year and trend-channel position of 2.56 standard deviations; price sits 8.0% over 200-day average and 16.2% over 50-day average.

Sagehood research decision

The investment case, main risk and break condition are the ones shown under Sagehood’s view at the top of this page.

Recorded break condition
Break condition as kept in the decision trail

A later reading showing TTM revenue growth below the 8.7% revenue-growth median would confirm the contraction already visible.

Evidence & sourcesClaim-support availability, filing-context links and research method

DOW: This run has no checked links from its claims to their evidence. The specialists’ writing is shown as recorded, and no missing evidence is filled in.

Research evidence at a glance

Accepted specialist evidence · no score adjustment

Key figures

Fundamentals

Trailing-twelve-month revenue was $39,331 million with revenue growth of −7.7% and quarterly revenue growth of −7.4%, −8.3%, −9.1% and −6.1%, while trailing-twelve-month free cash flow was −$232 million against trailing-twelve-month operating cash flow of $2,065 million.

Valuation model

The DCF was not computed because debt and net debt are unavailable, leaving no grid fair value, while the two-name comps median of $83.08 implies 139.4% upside against the $34.70 close and trailing-twelve-month free cash flow is −$232 million on a −0.6% FCF margin.

Potential upside

  • No DCF grid was computed because debt and net debt are unavailable, so the fair value is not available and the score sits at neutral. The two-name comps median of $83.08 implies 139.4% upside, but the −0.6% trailing-twelve-month FCF margin and −7.7% revenue growth leave the read unanchored.

Potential downside

  • Dow shows a contracting top line, with trailing-twelve-month revenue of $39,331 million down 7.7% and trailing-twelve-month free cash flow of −$232 million, while total debt and net debt to EBITDA are not available, leaving the balance-sheet risk unquantified.

Questions to watch

  • A later reading showing trailing-twelve-month revenue growth below the 8.7% revenue-growth median would confirm the contraction already visible.

  • A later filing supplying debt and net debt would allow a grid fair value to be computed, and a fair value below the $34.70 close would break the comps-implied upside case.

Accepted research

Research dated 2026-10-30.

How this research was made

This research is AI-generated and is not investment advice.

Research date
2026-10-30
Valuation & peersInput limits notedFair-value cells, peer multiples and the inputs behind the range

Cash-flow model unavailable

Against the 2026-10-30 close of $34.70 (recorded)

Fundamentals reference date: 2026-03-31 · a newer 10-Q (filed 2026-10-23) is on record; some figures here may predate it.

Cash-flow model unavailable: the recorded total debt, net debt are missing or invalid. Other valuation methods retain their own checks.

Implied by the median of 2 peer-median multiples: $83.08 (+139.4% vs close)

Peers: the 2 Liquid 100 names in Materials that this run priced. Companies outside the Liquid 100 are not in the set.

The names: FCX, MOS.

Multiples against the peer group

Materials · 2 companies in the group

  • Price to earnings (trailing twelve months)Not computed in this research

    Peer median 30.62× · middle half 30.62× to 30.62×

  • Price to sales0.64×

    Peer median 2.02× · middle half 1.25× to 2.80× · 50th percentile of the group

  • Price to book1.55×

    Peer median 2.50× · middle half 1.51× to 3.50× · 50th percentile of the group

  • Free cash flow yield−0.93%

    Peer median −16.22% · middle half −16.22% to −16.22% · 100th percentile of the group

This run declares Enterprise value to EBITDA and computes no value for it, for this company or for its peer group.

Evidence limits: 17 valuation inputs required conservative handling: another valuation input required conservative handling; no full-year gross-profit line was filed; no full-year operating income was filed; total debt was unavailable; tax expense is not among this research’s inputs; depreciation and amortization were available but not used because this version does not compute an EV/EBITDA multiple; debt coverage was incomplete.

Includes the currently displayed specialist or comparison, not every specialist. Dates and limitations remain attached.

Sagehood research is for general information. It is not individualized investment advice or a recommendation to buy or sell any security.

Dow Inc. (DOW) research | Sagehood